• Investing
  • Stock
  • Editor’s Pick
  • Economy
The Significant Deals
Stock

Roche comes out against clearing takeover of drug manufacturer Catalent

by October 23, 2024
written by October 23, 2024

By Ludwig Burger

FRANKFURT (Reuters) – The CEO of pharmaceuticals giant Roche has urged authorities to block the takeover of contract drug manufacturer Catalent (NYSE:CTLT) by Novo Nordisk (NYSE:NVO)’s controlling shareholder, citing harm to industry peers.

“It’s not a problem for us, but it could be a problem for other smaller players, if there is a restriction in how many (contract manufacturers) are available,” Roche’s CEO Thomas Schinecker said in a media call. “From an industry perspective, it would be a wrong decision by authorities.”

He spoke after the release of quarterly sales on Wednesday.

Last week, U.S. consumer groups and labour unions petitioned the U.S. Federal Trade Commission to block Novo Holdings, the controlling shareholder of Novo Nordisk, from acquiring Catalent, saying the deal threatened competition in weight loss drugs and cutting-edge gene therapies.

The groups said at the time that the deal could constrain options for competitors such as Amgen (NASDAQ:AMGN), Pfizer (NYSE:PFE), Roche and AstraZeneca (NASDAQ:AZN), which are reportedly developing their own obesity drugs, some of which are based on difficult-to-make peptides.

Viking Therapeutics (NASDAQ:VKTX), Structure Therapeutics and Sun Pharma could also be affected, the groups said.

Novo Holdings has said it believes in a “pro-competitive rationale” for the transaction.

The head of Roche’s pharmaceutical division, Teresa Graham, underscored on Wednesday that Roche itself was not impacted: “We are quite confident in the capacity we have. We have reserved capacity with other CMOs (contract manufacturing organisations).”

Roche has previously said it would use a mix of in-house and external manufacturing for future commercial production of its obesity drugs.

This post appeared first on investing.com
0 comment
0
FacebookTwitterPinterestEmail

previous post
European stocks could rally after US election into 2025, Barclays says
next post
Maldives to focus on managing debt bilaterally, ends work with Centerview

You may also like

BASF results down on impairments, restructuring

January 27, 2025

European chipmakers slump as traders gauge DeepSeek AI...

January 27, 2025

Nasdaq futures tumble as China’s AI push rattles...

January 27, 2025

China Vanke’s CEO, chairman resign amid growing liquidity...

January 27, 2025

Fuji Media, rocked by sexual misconduct allegations, says...

January 27, 2025

Italy’s MPS shares fall ahead of Mediobanca board...

January 27, 2025

British Land stock drops following stake sale

January 27, 2025

UMG shares rally after new multi-year pact with...

January 27, 2025

BASF shares indicated 3% lower as impairments drag...

January 27, 2025

Ryanair cuts 2026 traffic forecast amid ongoing Boeing...

January 27, 2025
Fill Out & Get More Relevant News








    Stay ahead of the market and unlock exclusive trading insights & timely news. We value your privacy - your information is secure, and you can unsubscribe anytime. Gain an edge with hand-picked trading opportunities, stay informed with market-moving updates, and learn from expert tips & strategies.

    Recent Posts

    • Divided Fed proposes rule to ease capital requirements for big Wall Street banks

      June 26, 2025
    • Women’s Tennis Association extends media rights deal with Tennis Channel through 2032

      June 26, 2025
    • Bumble shares jump 26% as dating company plans to axe 30% of workforce

      June 26, 2025
    • Small-business AI use is lagging, but one firm is channeling Sherlock Holmes and knocking out ‘grunt work’

      June 25, 2025

    Categories

    • Economy (245)
    • Editor's Pick (3,646)
    • Investing (534)
    • Stock (6,426)

    Latest News

    • Divided Fed proposes rule to ease capital requirements for big Wall Street banks
    • Women’s Tennis Association extends media rights deal with Tennis Channel through 2032

    Popular News

    • Morning Bid: Reality check for China stocks, dollar rips higher
    • Freeport-McMoran beats Q3 estimates, revenue up 17% YoY

    About The Significant deals

    • Privacy Policy
    • Terms & Conditions

    Copyright © 2025 thesignificantdeals.com | All Rights Reserved

    The Significant Deals
    • Investing
    • Stock
    • Editor’s Pick
    • Economy